2015 ASH Annual Meeting - Complete Meeting
Description
As the premier event in malignant and non-malignant hematology, the ASH annual meeting provides attendees with an outstanding educational experience that examines the latest clinical advances in hematology and explores the year's most significant scientific discoveries and updates. The videos make this event available for convenient, on-demand viewing.
ASH now offers three package options, where you can choose between scientific and educational content, or purchase both at a lower price.
The 2015 ASH Annual Meeting webcast (full package) includes all of the following sessions:
- General Sessions
- Special-Interest Sessions
- Trainee Simultaneous Didactic Sessions
- Education Program Sessions
- Education Spotlight Sessions
- Scientific Program Sessions [NEW]
- Special Scientific Symposia [NEW]
- Scientific Spotlight Sessions [NEW]
Pricing
| Member Type | Price |
|---|---|
| List Price | $600.00 |
| Active, International, Emeritus, and Honorary Members | $350.00 |
| Associate, International Associate, Student, and Resident Members | $150.00 |
Sessions
- Addressing Severe Thrombocytopenia in the Care of Patients with Myelodysplastic Syndromes and Other Hematological Malignancies
- Advances in the Understanding and Diagnosis of Myelodysplasia and Bone Marrow Failure Syndromes
- Aging and Thrombosis
- Anemia: When Something's Wrong with Iron
- Announcement of Awards: Mentor Award, Outstanding Service Award, Public Service Award, Wallace H. Coulter Award for Lifetime Achievement in Hematology
- Announcement of Awards: William Dameshek Prize, Henry M. Stratton Medal
- ASH/ASCP Summit on Myelodysplastic Syndromes
- ASH/EHA Joint Symposium
- ASH/FDA Joint Symposium on Late-Breaking Drug Approvals
- Best of ASH
- Beyond Transcription: Translational Control of Gene Expression in Development and Disease
- Challenges in Hemophilia Care
- Challenging Anticoagulation Scenarios
- Challenging Scenarios in Thrombosis
- Checkpoint, Please?
- Clonal Architecture and Hierarchy: Implications for Biology and Translation
- Contemporary Therapy of Lymphoma
- Cytosis: Too Much of a Good Thing
- Determinants of Clot Structure: Beyond Fibrin
- E. Donnall Thomas Lecture and Prize
- Ernest Beutler Lecture and Prize
- Evolving Issues in Anticoagulation
- Genetics vs. Response: What Should Direct Future Therapy of Childhood Acute Lymphoblastic Leukemia?
- Genome Therapies for Hemoglobinopathies
- Genomically Engineered Stem Cells: A Brave New World for Therapeutics
- Genomics, The Next Frontier: Novel Approaches to Study Cancer and Development
- Great Expectations: Hematology in Pregnancy
- Guiding Hematologic Care with Genetic Testing
- Ham-Wasserman Lecture: Game of Clones: Genomic Evolution of Severe Congenital Neutropenia
- Harnessing T Cells in Therapy of Hematologic Malignancy
- Hematopoiesis and the Niche
- Hemophagocytic Lymphohistiocytosis in Adults
- How to Get Published in a Peer-Reviewed Journal
- Imaging and Treating the Clot: What's New?
- Immunological Ctrl-Alt-Del: Stem Cell Transplantation For Hematological Malignancies
- Infections and the Blood Supply
- Inflammatory Signaling: Tailoring Myelopoiesis in Health and Disease
- Junior-Faculty Development Education Session: Understanding the Basics of the Academic Job
- Management of Challenging Bleeding Complications
- Managing Typical and Atypical Chronic Myeloid Leukemia
- Mechanism of Phosphatidylserine Exposure
- Multiple Advances In Myeloma
- Myelodysplastic Syndromes: Evolving Diagnosis and Therapy
- Myeloproliferative Neoplasms: A Clinical Update
- New Approaches in Chronic Lymphocytic Leukemia and Prolymphocytic Leukemia
- New Insights in Hemolytic Anemia
- Novel Approaches to Acute Lymphoblastic Leukemia
- Optimal Delivery of the Neonate with a Bleeding Disorder
- Optimizing Therapy in Sickle Cell Disease
- Optimizing Transfusion Therapy (AABB Session)
- Overcoming Obstacles to Activating and Accruing in Clinical Trials on Hematological Malignancies
- Overcoming the Barrier of TP53 Dysfunction to Cure Blood Cancers
- Palliative Care in Hematological Malignancies
- Patient-Reported Outcomes in Hematology
- Pediatric Hematological Malignancies: Beyond Acute Lymphocytic Leukemia
- Plasma Cell Disorders Other Than Myeloma
- Practical Management of T-Cell and Natural Killer Cell Lymphomas
- Precision Medicine in Cancer Therapy: N-of-1
- Presidential Symposium
- Recent Advances in Histiocytic Neoplasms
- Recent Insights into Efficacy of Red Blood Cells in Transfusions and Physiology
- Returning Diagnostic, Uncertain and Incidental Genomic Results
- Send in the Clones: Stem Cell Succession, Replicative Stress and Somatic Reversion
- Social Media for the Hematologist
- Special Education Session on Newly Approved Drugs
- Special Symposium on Quality
- Special Symposium on the Basic Science of Hemostasis and Thrombosis
- Take a Breath: Heme, Iron, and Cellular Metabolism
- Targeting the Epigenome
- Targeting the Tumor Microenvironment in Lymphoid Malignancies
- Telomeres and Bone Marrow Failure
- The ASH Choosing Wisely® Campaign: Top 5 Non-ASH Choosing Wisely® Recommendations of Relevance to Hematology
- The Epic Story of Blood
- The Path Toward Curing Multiple Myeloma
- Trainee Simultaneous Didactic Session: Application of Microarray, Next Generation Sequencing, and Large Datasets to Hematology and Bioinformatics
- Trainee Simultaneous Didactic Session: Career Choice: Academic vs. Practice vs. Industry
- Trainee Simultaneous Didactic Session: How to Give Feedback to Students and Employees
- Trainee Simultaneous Didactic Session: How to Set Up a Laboratory Based Research Program
- Treatment of Acute Myeloid Leukemia: Moving Beyond 3 + 7
- Update in Large Cell Lymphoma
- Update on Diagnosis and Management of Thrombotic Thrombocytopenic Purpura
ASH Academy
Now offering malignant and non-malignant hematology testing modules that provide both MOC and CME Credit.
Learn more
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
Copyright © 2017 by American Society of Hematology